Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphabet Inc. stock logo
GOOGL
Alphabet
$159.38
-0.8%
$161.69
$140.53
$207.05
$1.94T1.0328.24 million shs12.72 million shs
Microsoft Co. stock logo
MSFT
Microsoft
$393.00
+0.5%
$384.46
$344.79
$468.35
$2.92T121.08 million shs3.89 million shs
NVIDIA Co. stock logo
NVDA
NVIDIA
$108.91
+0.2%
$112.60
$81.25
$195.95
$2.65T1.96303.31 million shs62.26 million shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$5.78
-1.1%
$6.11
$3.79
$12.36
$2.32B112.25 million shs3.54 million shs
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$10.96
-0.1%
$10.95
$8.08
$18.83
$9.49B0.6720.96 million shs1.87 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphabet Inc. stock logo
GOOGL
Alphabet
-0.83%+8.76%+4.07%-17.76%-6.59%
Microsoft Co. stock logo
MSFT
Microsoft
-0.18%+8.92%+3.26%-12.54%-3.73%
NVIDIA Co. stock logo
NVDA
NVIDIA
-2.03%+12.22%-0.83%-14.90%+23.96%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
+1.92%+7.95%+0.52%-21.40%-28.08%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-0.36%+0.92%-1.97%+0.73%-38.02%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphabet Inc. stock logo
GOOGL
Alphabet
4.0017 of 5 stars
3.43.01.70.02.62.52.5
Microsoft Co. stock logo
MSFT
Microsoft
4.8803 of 5 stars
4.43.03.32.92.81.71.9
NVIDIA Co. stock logo
NVDA
NVIDIA
4.8719 of 5 stars
4.53.01.73.03.32.51.9
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.2465 of 5 stars
3.22.00.00.02.62.50.6
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
2.8537 of 5 stars
0.95.02.52.31.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphabet Inc. stock logo
GOOGL
Alphabet
2.88
Moderate Buy$198.8924.79% Upside
Microsoft Co. stock logo
MSFT
Microsoft
2.87
Moderate Buy$493.8925.67% Upside
NVIDIA Co. stock logo
NVDA
NVIDIA
2.93
Moderate Buy$164.9651.47% Upside
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.33
Hold$8.2041.99% Upside
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
1.83
Reduce$10.59-3.32% Downside

Current Analyst Ratings Breakdown

Latest GOOGL, MSFT, RXRX, NVDA, and WBA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/25/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$195.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$178.00 ➝ $178.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $195.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$165.00 ➝ $185.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $195.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$173.00 ➝ $186.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$225.00 ➝ $220.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$195.00 ➝ $200.00
4/25/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform$185.00 ➝ $200.00
(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphabet Inc. stock logo
GOOGL
Alphabet
$359.71B5.40$8.18 per share19.49$26.67 per share5.98
Microsoft Co. stock logo
MSFT
Microsoft
$261.80B11.16$14.03 per share28.01$40.72 per share9.65
NVIDIA Co. stock logo
NVDA
NVIDIA
$130.50B20.36$0.96 per share112.93$1.72 per share63.32
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$58.49M39.69N/AN/A$1.98 per share2.92
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$151.95B0.06$5.99 per share1.83$13.91 per share0.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphabet Inc. stock logo
GOOGL
Alphabet
$100.12B$8.9719.7915.581.3428.60%32.49%23.52%N/A
Microsoft Co. stock logo
MSFT
Microsoft
$88.14B$12.4231.6226.732.2135.43%33.36%18.07%4/30/2025 (Estimated)
NVIDIA Co. stock logo
NVDA
NVIDIA
$29.76B$2.9442.7927.361.7655.69%114.83%76.61%5/28/2025 (Estimated)
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$328.07M-$1.66N/AN/AN/A-579.52%-76.56%-55.68%5/8/2025 (Estimated)
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-$8.64B-$6.69N/A7.501.31-5.87%17.61%2.89%6/26/2025 (Estimated)

Latest GOOGL, MSFT, RXRX, NVDA, and WBA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.44N/AN/AN/A$18.12 millionN/A
4/30/2025Q3 2025
Microsoft Co. stock logo
MSFT
Microsoft
$3.20N/AN/AN/A$68.54 billionN/A
4/24/2025Q1 2025
Alphabet Inc. stock logo
GOOGL
Alphabet
$2.02$2.81+$0.79$2.81$89.30 billion$76.49 billion
4/8/2025Q2 2025
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.53$0.63+$0.10-$3.30$37.90 billion$38.59 billion
2/28/2025Q4 2024
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.36-$0.53-$0.17-$0.53$19.04 million$4.60 million
2/26/2025Q4 2025
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.84$0.89+$0.05$0.89$38.16 billion$39.33 billion
2/4/2025Q4 2024
Alphabet Inc. stock logo
GOOGL
Alphabet
$2.12$2.15+$0.03$2.15$96.67 billionN/A
1/29/2025Q2 2025
Microsoft Co. stock logo
MSFT
Microsoft
$3.15$3.23+$0.08$3.23$68.86 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphabet Inc. stock logo
GOOGL
Alphabet
$0.840.53%N/A9.36%N/A
Microsoft Co. stock logo
MSFT
Microsoft
$3.320.84%+10.22%26.73%23 Years
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.040.04%+33.42%1.36%N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$1.009.13%-19.12%N/A N/A

Latest GOOGL, MSFT, RXRX, NVDA, and WBA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
quarterly$0.210.53%6/9/20256/9/20256/16/2025
3/11/2025
Microsoft Co. stock logo
MSFT
Microsoft
quarterly$0.830.87%5/15/20255/15/20256/12/2025
2/26/2025
NVIDIA Co. stock logo
NVDA
NVIDIA
quarterly$0.010.03%3/12/20253/12/20254/2/2025
2/4/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
quarterly$0.200.4%3/10/20253/10/20253/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphabet Inc. stock logo
GOOGL
Alphabet
0.03
1.84
1.84
Microsoft Co. stock logo
MSFT
Microsoft
0.13
1.35
1.34
NVIDIA Co. stock logo
NVDA
NVIDIA
0.13
4.10
3.64
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
0.04
4.35
4.35
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.68
0.64
0.30

Institutional Ownership

CompanyInstitutional Ownership
Alphabet Inc. stock logo
GOOGL
Alphabet
40.03%
Microsoft Co. stock logo
MSFT
Microsoft
71.13%
NVIDIA Co. stock logo
NVDA
NVIDIA
65.27%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
58.59%

Insider Ownership

CompanyInsider Ownership
Alphabet Inc. stock logo
GOOGL
Alphabet
11.55%
Microsoft Co. stock logo
MSFT
Microsoft
0.03%
NVIDIA Co. stock logo
NVDA
NVIDIA
4.23%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
15.75%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
17.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alphabet Inc. stock logo
GOOGL
Alphabet
190,20012.19 billion10.78 billionOptionable
Microsoft Co. stock logo
MSFT
Microsoft
221,0007.43 billion7.43 billionOptionable
NVIDIA Co. stock logo
NVDA
NVIDIA
26,20024.40 billion23.45 billionOptionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
400401.99 million329.18 millionOptionable
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
325,000864.74 million712.93 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alphabet stock logo

Alphabet NASDAQ:GOOGL

$159.38 -1.23 (-0.77%)
As of 11:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play and YouTube; and devices, as well as in the provision of YouTube consumer subscription services. The Google Cloud segment offers infrastructure, cybersecurity, databases, analytics, AI, and other services; Google Workspace that include cloud-based communication and collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells healthcare-related and internet services. The company was incorporated in 1998 and is headquartered in Mountain View, California.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$393.00 +1.84 (+0.47%)
As of 11:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$108.91 +0.18 (+0.16%)
As of 11:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Recursion Pharmaceuticals stock logo

Recursion Pharmaceuticals NASDAQ:RXRX

$5.78 -0.07 (-1.11%)
As of 11:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Walgreens Boots Alliance stock logo

Walgreens Boots Alliance NASDAQ:WBA

$10.96 -0.02 (-0.14%)
As of 11:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.